ZUX-70591-40870 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-06
Dose 1 — Pfizer-BioNTech
2021-04-08
Registered in v-safe
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-04-27
Dose 2 — Pfizer-BioNTech
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site

Adult check-in
2021-05-03
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Rash, not including the immediate area around the injection site

Adult check-in
2021-05-13
Survey response — day 14, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Enlarged lymph nodes in/around underarm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-06-03
Survey response — day 35, dose 2
MedDRA: Contusion, Peripheral swelling, Swelling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Feet/calf swelling and bruise like spots appearing bilaterally

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-03
Report sent to call center — day 35, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-29
Survey response — 3 months, dose 2
MedDRA: Erythema nodosum, Office visit, Peripheral swelling — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Erythema Nodosum with ongoing leg swelling for 2 months · Healthcare visit (other): Biopsy, office visits

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-29
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-05
Call 1 — Left Voicemail
2021-10-26
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-03-10
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-04-27
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-04-27
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-06	Pfizer-BioNTech
2	2021-04-27	Pfizer-BioNTech
3	2022-03-10	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2021-06-03	Unsuccessful
2021-07-29	Unsuccessful

Free text

Release 8 — day 14, dose 2

2021-05-13

Symptoms: Enlarged lymph nodes in/around underarm

Release 8 — day 35, dose 2

2021-06-03

Symptoms: Feet/calf swelling and bruise like spots appearing bilaterally

Release 9 — 3 months, dose 2

2021-07-29

Symptoms: Erythema Nodosum with ongoing leg swelling for 2 months

Healthcare visit (other): Biopsy, office visits

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	·	✓
SD	Contusion	✓	✓	✓
SD	Erythema nodosum	✓	·	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Peripheral swelling	✓	✓	✓
SD	Swelling	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release